As triple-negative breast cancer (TNBC) is a special molecular subtype of HER2-negative breast cancer, which is defined by the absence of the ER, PR, and HER2 genes, with no standard treatment at present, we then explored the correlation of VDAC1 expression with the prognosis of TNBC. Here, ESR1 is linked to triple-negative breast carcinoma.